The objectives of the proposed studies can be summarized as follows: (A) To continue to define subcategories of """"""""broad spectrum"""""""" immunologic deficiency syndromes, based on inheritance patterns, results of immunogenetic and biochemical assays, and differences in response to immunotherapy, and to search for correlations, if any, with clinical differences. The WHO Expert Committee on Immunodeficiency has stated that their current classification of immunodeficiency disorders is admittedly incomplete, and indeed several disease entities listed as such have since been shown to be heterogeneous syndromes. (B) To search for close associations and possible linkage between one or another subcategory of immunodeficiency syndrome and immunogenetic markers, and to continue investigations aimed at the definition of """"""""new"""""""" allotypic markers of human immunoglobulins. (C) To continue the development of new test methods for further assessment of deficiencies in those cells associated with immunodeficiency (e.g., T and B cell populations and subpopulations, monocytes, granulocytes). (D) To investigate possible immunogenetic predisposition to several diseases of """"""""unknown etiology"""""""" (e.g., mu ltiple sclerosis, alopecia totalis) which are associated with inadequate or inappropriate immunologic response of one or another immunocyte population in hosts possessing rare """"""""deficient"""""""" immune response genes to the (unknown) etiologic agent involved (microbial, viral, etc.), and to continue our studies of cystic fibrosis, which is characterized by abnormal immunocytes and abnormal immunocyte products. We propose that many such diseases can best be understood as immune deficiency diseases of """"""""diseases of immunologic aberration"""""""" and that more effective modes of therapy can be devised on this basis. (E) To study the number and function of immunocyte populations in """"""""antigen selective"""""""" immune defects (severe recurrent infection with a single organism), and to determine whether such patients have an immunogenetic predisposition due to rare immune response genes. (F) To search for human antigens defined by immune response genes, using alloantisera produced previously by prolonged cross immunization, to test the hypothesis that rare """"""""broad spectrum"""""""" and """"""""antigen selective"""""""" immune deficiencies are associated with unusual immune response genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI018727-10
Application #
3128141
Study Section
(SSS)
Project Start
1978-12-01
Project End
1986-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
10
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
School of Medicine & Dentistry
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Chou, Y K; Stanley, W; Virella, G et al. (1987) Generation of phenotypically distinct macrophage-hepatoma hybrid clones. Immunobiology 174:444-59
Dirienzo, W; Stefanini, G F; Miribel, L et al. (1987) Alpha 1-acid glycoprotein (alpha 1-AGP) on the membrane of human lymphocytes: possible involvement in cellular activation. Immunol Lett 15:167-70
Singh, V K; Fudenberg, H H (1986) Can blood immunocytes be used to study neuropsychiatric disorders? J Clin Psychiatry 47:592-5
Galbraith, G M; Emerson, D; Fudenberg, H H et al. (1986) Antibodies to neurofilament protein in retinitis pigmentosa. J Clin Invest 78:865-9
Singh, V K; Fudenberg, H H (1986) Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome. Immunol Lett 12:277-80
Granoff, D M; McKinney, T; Boies, E G et al. (1986) Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak. Pediatrics 77:289-95
Stefanini, G F; Dirienzo, W; Arnaud, P et al. (1986) Inhibitory effect of an antibody against alpha 1-acid glycoprotein (alpha 1-AGP) on autologous mixed lymphocyte reaction and anti-T3 T-lymphocyte activation. Cell Immunol 103:65-72
Pandey, J P; Ebbesen, P; Bulow, S et al. (1986) IgG heavy-chain (Gm) allotypes in familial polyposis coli. Am J Hum Genet 39:133-6
Dirienzo, W; Stefanini, G F; Singh, V K et al. (1986) Does normal lymphocyte DNA synthesis in response to PHA exclude cell-mediated immunodepression? Clin Immunol Immunopathol 41:227-35
Leonardi, A; Caria, M; Arata, L et al. (1986) Evidence of T-lymphocyte functional impairment in Huntington's disease. Clin Immunol Immunopathol 39:121-30

Showing the most recent 10 out of 16 publications